Carretero P - Search Results

1

Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers.

Lafuente A, Pujol F, Carretero P, Villa JP, Cuchi A. Lafuente A, et al. Among authors: carretero p. Cancer Lett. 1993 Jan 15;68(1):49-54. doi: 10.1016/0304-3835(93)90218-x. Cancer Lett. 1993. PMID: 8422649

2

Myeloperoxidase activity and whole blood chemiluminescence in bladder cancer--influence of smoking.

Lafuente A, Pujol F, Carretero P, Trias M, Trush MA. Lafuente A, et al. Among authors: carretero p. Exp Toxicol Pathol. 1994 Dec;46(6):471-6. doi: 10.1016/S0940-2993(11)80064-3. Exp Toxicol Pathol. 1994. PMID: 7703679 Free article.

3

Influence of smoking in the glutathione-S-transferase M1 deficiency--associated risk for squamous cell carcinoma of the bladder in schistosomiasis patients in Egypt.

Lafuente A, Zakahary MM, el-Aziz MA, Ascaso C, Lafuente MJ, Trias M, Carretero P. Lafuente A, et al. Among authors: carretero p. Br J Cancer. 1996 Sep;74(5):836-8. doi: 10.1038/bjc.1996.445. Br J Cancer. 1996. PMID: 8795591 Free PMC article.

4

Limitations in the use of glutathione S-transferase P1 in urine as a marker for bladder cancer.

Lafuente A, Rodriguez A, Gibanel R, Lafuente MJ, Alonso M, Molina R, Ballesta A, Carretero P. Lafuente A, et al. Among authors: carretero p. Anticancer Res. 1998 Sep-Oct;18(5B):3771-2. Anticancer Res. 1998. PMID: 9854493

5

Expression of glutathione S-transferase activity and glutathione content in squamous cell carcinoma of bladder associated with schistosomiasis in a population in Egypt.

Ghazaly GE, Zakahary MM, el-Aziz MA, Mahmoud AA, Carretero P, Lafuente A. Ghazaly GE, et al. Among authors: carretero p. Scand J Urol Nephrol. 1997 Feb;31(1):43-7. doi: 10.3109/00365599709070301. Scand J Urol Nephrol. 1997. PMID: 9060083

6

Invasive bladder cancer in women.

Romero JA, Alvarez-Vijande R, Gutiérrez R, Vendrell R, Gil-Vernet JM Jr, Carretero P. Romero JA, et al. Among authors: carretero p. Arch Esp Urol. 1992 Oct;45(8):837-9. Arch Esp Urol. 1992. PMID: 1466591

7

TPA prognostic value in superficial bladder cancer.

Filella X, Menendez V, Molina R, Alcover J, Carretero P, Ballesta AM. Filella X, et al. Among authors: carretero p. Anticancer Res. 1996 Jul-Aug;16(4B):2173-5. Anticancer Res. 1996. PMID: 8694539

8

p53 expression predicts progression and poor survival in T1 bladder tumours.

Llopis J, Alcaraz A, Ribal MJ, Solé M, Ventura PJ, Barranco MA, Rodriguez A, Corral JM, Carretero P. Llopis J, et al. Among authors: carretero p. Eur Urol. 2000 Jun;37(6):644-53. doi: 10.1159/000020232. Eur Urol. 2000. PMID: 10828662

9

Neurogenic bladder in patients with acquired immunodeficiency syndrome.

Menéndez V, Valls J, Espuña M, Pérez A, Barranco MA, Carretero P. Menéndez V, et al. Among authors: carretero p. Neurourol Urodyn. 1995;14(3):253-7. doi: 10.1002/nau.1930140306. Neurourol Urodyn. 1995. PMID: 7647807

10

Clinical usefulness of free PSA fraction as an indicator of prostate cancer.

Filella X, Alcover J, Molina R, Giménez N, Rodríguez A, Jo J, Carretero P, Ballesta AM. Filella X, et al. Among authors: carretero p. Int J Cancer. 1995 Dec 11;63(6):780-4. doi: 10.1002/ijc.2910630605. Int J Cancer. 1995. PMID: 8847133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page